Amyloid-beta, alpha-synuclein and tau aggregated co-pathologies enhance neuropathology and neuroinflammation
Jhodi M. Webster,William J. Stone,Ya-Ting Yang,Aidan T. Miller,Gabrielle M. Childers,Nicole J. Corbin-Stein,Nikhita Mudium,Jeremy Molina,Woong-Jai Won,Ivette M. Sandoval,Daniel J. Tyrrell,Fredric P. Manfredsson,Jeffrey H. Kordower,Ashley S. Harms
DOI: https://doi.org/10.1101/2024.10.13.618101
2024-10-13
Abstract:Lewy pathology due to alpha-synuclein (α-syn) inclusions is one of the major hallmarks of Parkinson Disease (PD). Αβ-Amyloid (Aβ) and phosphorylated tau, pathologies usually found in Alzheimers Disease (AD), have also been implicated in PD, with over 50% of patients exhibited the co-expression of these proteins (co-pathologies). In both AD and PD postmortem tissue, neuroinflammation, the activation of microglia and resident macrophages and the infiltration of immune cells from the periphery, including T cells and monocytes, are drivers of neurodegeneration. However, how the co-expression of these pathologies contribute to the inflammatory response and overall neurodegenerative disease phenotype remains unknown. To understand how the co-expression of pathologies drives neuropathology, we developed a novel co-pathology model by stereotaxically injecting α-syn pre-formed fibrils (PFFs) into the striatum, and AAV-doublemut tau virus into the entorhinal cortex, of 3-month-old J20 transgenic mice with Aβ pathology. We analyzed immune cell populations in the brain and periphery at 3 months post-induction (3MPI). At 6MPI, neuronal loss in the hippocampus and substantia nigra pars compacta were assessed along with pathological protein deposition. At 3MPI, the co-pathology mouse model begins to exhibit enhanced pathology load in the cortex and hippocampus. There was a robust neuroinflammatory response in interconnected brain regions, including increased microglial cell number, changes in microglial activation markers, and infiltration of T cells. This was synergistic in the co-pathology model, compared to the individual models, supporting the hypothesis that these collectively may drive the progression of disease.
Neuroscience